jr. introduces bipartisan 2016 colorectal cancer detection act 10.08.2016 epigenomics ag announces 2016 second quarter and six months financial results and reports on operational highlights 10.08.2016 epigenomics ag confidentially submits draft registration statement for potential u.s. public offering of adss crc screening using septin9 are you a patient and interested in early detection of colorectal cancer for more information please click hereare you a physician and interested in a new and high performance test for detection of crc for your patients for more information please click herethese laboratories are offering the septin9 test for more information please click here visit website visit website epigenomics ag 2016 imprint disclaimer general terms and conditions data protection statement